Literature DB >> 19571109

An oral Mycobacterium bovis BCG vaccine for wildlife produced in the absence of animal-derived reagents.

Martin L Cross1, Matthew R Lambeth, Frank E Aldwell.   

Abstract

Cultures of Mycobacterium bovis BCG, comprising predominantly single-cell bacilli, were prepared in broth without animal-derived reagents. When formulated into a vegetable-derived lipid matrix, the vaccine was stable in vitro and was immunogenic in vivo upon feeding it to mice. This formulation could be useful for oral vaccination of wildlife against tuberculosis, where concern over transmissible prions may preclude the field use of vaccines containing animal products.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571109      PMCID: PMC2745018          DOI: 10.1128/CVI.00198-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  11 in total

1.  Cultivation of Mycobacterium bovis BCG in bioreactors.

Authors:  Guido Dietrich; Hans-Joachim Mollenkopf; Heinz Weber; Bernhard Knapp; Klaus-Dieter Diehl; Jürgen Hess; Friedrich Blackkolb; Michael Bröker; Stefan H E Kaufmann; Erika Hundt
Journal:  J Biotechnol       Date:  2002-07-03       Impact factor: 3.307

2.  Oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG.

Authors:  Martin L Cross; Frank Aldwell
Journal:  Expert Rev Vaccines       Date:  2007-06       Impact factor: 5.217

3.  Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.

Authors:  Y Tabata; Y Inoue; Y Ikada
Journal:  Vaccine       Date:  1996-12       Impact factor: 3.641

4.  Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity.

Authors:  M L Cross; M R Lambeth; Y Coughlan; F E Aldwell
Journal:  Vaccine       Date:  2006-10-12       Impact factor: 3.641

Review 5.  Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.

Authors:  C E Rupprecht; C A Hanlon; D Slate
Journal:  Dev Biol (Basel)       Date:  2004

6.  Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums.

Authors:  D M Tompkins; D S L Ramsey; M L Cross; F E Aldwell; G W de Lisle; B M Buddle
Journal:  Proc Biol Sci       Date:  2009-06-03       Impact factor: 5.349

7.  Lipid-formulated bcg as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand.

Authors:  Martin L Cross; Ray J Henderson; Matthew R Lambeth; Bryce M Buddle; Frank E Aldwell
Journal:  J Wildl Dis       Date:  2009-07       Impact factor: 1.535

8.  Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.

Authors:  Frank E Aldwell; Ian G Tucker; Geoffrey W de Lisle; Bryce M Buddle
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Protection of free-living and captive possums against pulmonary challenge with Mycobacterium bovis following oral BCG vaccination.

Authors:  D S L Ramsey; F E Aldwell; M L Cross; G W de Lisle; B M Buddle
Journal:  Tuberculosis (Edinb)       Date:  2009-01-10       Impact factor: 3.131

10.  Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums.

Authors:  Frank E Aldwell; Denise L Keen; Natalie A Parlane; Margot A Skinner; Geoffrey W de Lisle; Bryce M Buddle
Journal:  Vaccine       Date:  2003-12-08       Impact factor: 3.641

View more
  2 in total

1.  Influence of vehicles used for oral dosing of test molecules on the progression of Mycobacterium tuberculosis infection in mice.

Authors:  Shubhra Singh; Richa Dwivedi; Vinita Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

Review 2.  Development and Challenges in Animal Tuberculosis Vaccination.

Authors:  Ana Balseiro; Jobin Thomas; Christian Gortázar; María A Risalde
Journal:  Pathogens       Date:  2020-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.